Background {#Sec1}
==========

Acid-base disturbances due to either the underlying pathological process or intensive care therapy are common in critically ill patients. Broadly speaking, there are three approaches to assess acid-base disturbances, including the physiological approach, the base excess (BE) approach and the physical-chemical approach \[[@CR1]\]. The physiological approach uses the Henderson-Hasselbalch equation, and arterial pH is assumed to be solely determined by the balance between arterial carbon dioxide tension (respiratory component) and plasma bicarbonate concentration (metabolic component). The BE approach has some similarities to the physiological approach, but it uses the BE instead of bicarbonate to define the metabolic component of acid-base disturbances. BE is estimated by how much acid or base is needed to adjust the pH back to 7.40 while correcting the arterial carbon dioxide tension to 40 mmHg. Further refinement of these approaches includes anion gap (AG) with and without correcting for hypoalbuminaemia (AG-corrected) to define whether excessive anions other than chloride (Cl^−^) and bicarbonate are present.

The third approach to quantify acid-base disturbances is the physical-chemical approach, also called Stewart's acid-base approach. In this approach, the three main determinants of acid-base status are (i) total carbon dioxide content in vitro (representing carbon dioxide in both dissolved and undissolved forms) or partial pressure of carbon dioxide in vivo, (ii) the weak non-volatile acids (mainly albumin and phosphate) and (iii) the strong ion difference. Strong ion difference (SID-apparent or SIDa) is the difference between the amount of fully dissociated cations (Na^+^, K^+^, Ca^2+^, Mg^2+^) and anions (Cl^−^). The physical-chemical approach to acid-base is more comprehensive than the other two approaches and can identify subtle or combined acid-base disturbances that are not apparent using the physiological or BE approach alone \[[@CR2], [@CR3]\]. Furthermore, recent evidence suggested that abnormalities in SIDa or strong ion gap (SIG) are associated with severity of inflammation, suggesting that abnormal Stewart's acid-base status may have pathogenic consequences and hence prognostic significance \[[@CR4]\]. Stewart's approach to acid-base disturbances is, however, more complicated than the physiological and BE approaches, and unless such data are automatically generated from the laboratory, a smartphone application may be needed to facilitate interpretation \[[@CR1]\].

We hypothesised that SIG may be more important than the other acid-base markers, and Stewart's approach to acid-base disturbances may be superior to other markers of acid-base status in predicting mortality of critically ill patients \[[@CR5], [@CR6]\]. If this is the case, it would be essential for SIG to be determined and monitored regularly in critically ill patients. In this cohort study, we compared the prognostic significance of SIG with other commonly used acid-base markers and determined whether SIG is better than other acid-base markers, either by itself or when combined with a validated prognostic model, in predicting hospital mortality of the critically ill.

Methods {#Sec2}
=======

In this study, the physiological and biochemical data of the patients on admission to the ICU at the Royal Perth Hospital Intensive Care Unit (ICU) between 1 January 2008 and 31 December 2013 were analysed. Royal Perth Hospital is a 450-bed university teaching hospital, and the 20-bed ICU is a tertiary ICU, staffed by fully trained intensivists, admitting critically ill adult patients of all specialties with the exception of liver transplantation. The dataset contained all the components of the Simplified Acute Physiology Score (SAPS) III \[[@CR7]\], Acute Physiology and Chronic Health Evaluation (APACHE) II score \[[@CR8]\] and Admission Mortality Prediction Model (MPM~0~ III) \[[@CR9]\], as well as biochemical data required to estimate AG, SIDa and SIG in the blood tests obtained within the first hour of ICU admission \[[@CR10]\]. The data on SIG and SIDa were not automatically generated by the laboratory, and none of the clinicians in the study centre used Stewart's approach to diagnose and manage acid-base disturbances.

The study data were checked for transcription errors and completeness by a designated trained clerical staff member, using data from the computerised laboratory database and going through the ICU vital signs flow chart again before the data were transferred to the computer. A single data custodian was responsible for ensuring data quality. The data were reviewed for internal consistency, and there were no patients lost to follow-up or with missing hospital mortality data. This study utilised only clinical data that were de-identified and all ICU readmissions during the same hospitalisation were excluded, was registered as a clinical audit with the Clinical Safety and Quality Unit (150521-02) and was exempt from review by the Royal Perth Hospital Ethics Committee.

In this study, we compared the prognostic significance of SIG with other commonly used acid-base markers, including pH, carbon dioxide tension, actual (calculated) bicarbonate, Cl^−^, lactate, AG, AG-corrected, actual (calculated) BE, SID-effective and SIG (with \[[@CR5]\] and without including lactate as part of SIG \[[@CR3]\]) (Radiometer®, Copenhagen, Denmark), using arterial blood specimens of the study patients all obtained within the first hour of ICU admission. In addition, other ions that were unmeasured, also called the 'other' or 'other unmeasured ions' \[[@CR1]\], were also estimated by subtracting the water, Cl^−^ and protein effect from the BE. The methods to estimate and calculate AG, AG-corrected, SIDa (with and without including lactate in the calculations), SID-effective (SIDe), SIG (with and without including lactate in the calculations) and 'other unmeasured ions' (or BE gap) are described in [Appendix 1](#Sec9){ref-type="sec"}.

Statistical analysis {#Sec3}
--------------------

After confirming that the acid-base markers did not have an extreme U-shape relationship with the observed risks of death ([Appendix 2](#Sec10){ref-type="sec"}) which may compromise the accuracy of the area under the receiver operating characteristic curve (AUROC) analysis \[[@CR11]\], AUROC was used to compare the discrimination ability of different acid-base markers. The difference in AUROC between different acid-base markers derived from the same patients was calculated by the *z* statistic as described by Hanley and McNeil \[[@CR12]\]. We then assessed whether each of these acid-base markers would improve the ability of the MPM~0~ III model to predict hospital mortality of the critically ill patients by combining each of these markers with the predicted risks of MPM~0~ III \[[@CR13]\], also by AUROC. In addition, we also assessed whether SIG (with lactate included as part of SIG) or SIDe was superior to arterial lactate concentration in explaining the variability in the observed hospital mortality, based on each predictor's chi square contribution in a multivariate logistic regression \[[@CR14]\], while adjusting for the MPM~0~ III predicted risks. The MPM~0~ III prognostic model was primarily chosen as the preferred risk adjustment model in this study because it does not utilise any laboratory markers of acid-base status, and hence, no one acid-base marker was favoured in terms of its prognostic significance due to multicollinearity with the risk adjustment prognostic model in the AUROC and logistic regression analyses.

Finally, four separate sensitivity analyses were performed; one analysis was on patients with known cirrhosis to assess whether SIG, SIDe or bilirubin concentration was better than arterial lactate in predicting mortality as this specific subgroup of patients was known to have substantial accumulation of unmeasured anions \[[@CR15], [@CR16]\]. The second sensitivity analysis was conducted by replacing the MPM~0~ III predicted risks with the SAPS III predicted risks to assess whether SIG or SIDe would be better than lactate concentrations when a different risk adjustment tool was used. The third sensitivity analysis was to assess whether the AUROC of the predictors that had some degree of U-shape relationship to mortality (pH, chloride, bicarbonate and arterial carbon dioxide tension) ([Appendix 2](#Sec10){ref-type="sec"}) would change substantially after centring these predictors \[[@CR11]\]. In the last sensitivity analysis, we analysed all acid-base markers in a multivariate analysis, allowing non-linearity by a 3-knot restricted cubic spline function for all acid-base markers \[[@CR14], [@CR17]\].

In this study, a *p* value \< 0.05 was taken as significant and all statistical analyses were performed by SPSS for Windows (version 22.0, IBM, USA), MedCalc for Windows (version 12.5, Ostend, Belgium) or S-PLUS (version 8.0, 2007; Insightful Corp., Seattle, WA, USA).

Availability of data and materials {#Sec4}
----------------------------------

The SPSS dataset supporting the findings of this study will be provided if the readers contact the corresponding author.

Results {#Sec5}
=======

Of the 6878 patients included in the study (Fig. [1](#Fig1){ref-type="fig"}), 924 patients (13.4 %) died during the same hospitalisation after ICU admission. The patients who died were older, with more comorbidities and a higher acuity of acute illness (Table [1](#Tab1){ref-type="table"}). Except for plasma chloride concentrations, all acid-base markers on admission to the ICU were significantly different between hospital survivors and non-survivors (Table [2](#Tab2){ref-type="table"}).Fig. 1Flow chart showing inclusion and exclusion of patients in this studyTable 1Characteristics of the study cohortVariableTotal cohort (*n* = 6878)Survivors (*n* = 5954)Non-survivors (*n* = 924, 13.4 %)*p* value^a^Age, years (IQR)54.4 (38--69)53.2 (36--67)62.9 (48--75)0.001Male, no. (%)4504 (66)3930 (66)574 (62)0.023ICU admission source, no. (%)0.001- Operating theatre3166 (46)2919 (49)247 (27)- Emergency department1813 (26)1508 (25)305 (33)- Ward574 (8)422 (7)152 (16)- CCU/HDU286 (4)213 (4)73 (8)- Other hospital930 (14)806 (14)124 (13)- Other hospital ICU55 (1)42 (1)13 (1.4)Elective surgery, no. (%)1881 (27)1798 (30)83 (9)0.001Ward stay before ICU, days (IQR)5 (2--10)5 (2--10)4 (2--13)0.958Mechanical ventilation on adm (%)5412 (79)4677 (79)735 (80)0.383Acute renal failure on adm, no. (%)^b^392 (6)185 (3)207 (22)0.001Worst 24-h APACHE II score (IQR)17.0 (12--22)16 (12--21)27 (21--32)0.001SAPS III score (IQR)43 (34--54)41 (33--50)60 (51--68)0.001SAPS III predicted risk, % (IQR)7.9 (3--22)6.3 (2--16)32.8 (17--49)0.001MPM~0~ III predicted risk, % (IQR)15.7 (8--31)13.9 (7--26)41.5 (22--68)0.001ICU stay, days (IQR)3 (2--6)3 (2--6)4 (2--7)0.001Hospital stay, days (IQR)13 (7--25)14 (8--26)6 (3--17)0.001Chronic medical conditions (%)^b^- Respiratory314 (5)264 (4)50 (5)0.203- Cardiovascular679 (10)579 (10)100 (11)0.313- Liver167 (2)127 (2)40 (4)0.001- Renal323 (5)244 (4)79 (9)0.001- Immune disease69 (1)51 (0.9)18 (2)0.004- Immune treatment252 (4)185 (3)67 (7)0.001- Metastatic cancer93 (1)71 (1)27 (2)0.008- Lymphoma39 (0.6)25 (0.4)14 (2)0.001- Leukaemia/myeloma83 (1)53 (0.9)30 (3)0.001- AIDS7 (0.1)3 (0.05)4 (0.4)0.008Major admission diagnoses, no. (%) Cardiac or respiratory arrest345 (5)182 (3)163 (18)0.001 Pneumonia265 (4)23 (4)42 (5)0.233 Septic shock36 (6)324 (5)112 (12)0.001 Multiple trauma491 (7)455 (8)36 (4)0.001 Isolated head trauma620 (9)526 (9)94 (10)0.195 Intracranial haemorrhage235 (3)154 (3)81 (9)0.001 Drug overdoses449 (7)441 (7)8 (0.9)0.001 Congestive heart failure, ischaemic heart disease or cardiogenic shock179 (3)129 (2)50 (5)0.001 Peripheral vascular disease or aortic aneurysm205 (3)184 (3)21 (2)0.211 GI obstruction or perforation161 (2)134 (2)27 (3)0.200 Aspiration pneumonia76 (1)68 (1)8 (0.9)0.611 Obstructive airway disease136 (2)127 (2)9 (1)0.015 Heart valve surgery516 (8)503 (8)13 (1)0.001 Coronary artery bypass graft surgery982 (14)958 (16)24 (3)0.001 Acute lung injury or ARDS27 (0.4)22 (0.4)5 (0.5)0.398 Gastrointestinal bleeding125 (2)106 (2)19 (2)0.511 Pulmonary embolism22 (0.3)16 (0.3)6 (0.6)0.106All values are median and interquartile range (IQR) in parenthesis unless stated otherwise*Adm* admission, *GI* gastrointestinal, *APACHE* Acute Physiology and Chronic Health Evaluation, *ARDS* acute respiratory distress syndrome, *CCU* coronary care unit, *HDU* high dependency unit, *ICU* intensive care unit, *MPM* ~*0*~ *III* Mortality Prediction Model on admission, *SAPS* Simplified Acute Physiology Score^a^ *p* values generated by either Mann-Whitney or chi square test^b^According to the definitions by the APACHE modelTable 2Differences in different markers of acid-base disorders at ICU admission between survivors and non-survivors (*n* = 6878)Acid-base markersSurvivors (*n* = 5954)Non-survivors (*n* = 924)*p* value^a^1. Arterial pH7.35 (7.29--7.39)7.28 (7.17--7.37)0.0012. Arterial CO~2~ tension, mmHg40 (35--45)40 (34--48.8)0.0223. Actual bicarbonate conc., mmol/L21 (19--23)18 (14--21.8)0.0014. Chloride conc., mmol/L110 (107--113)109 (105--114)0.8915. Lactate conc., mmol/L1.5 (1.0--2.4)2.7 (1.4--5.6)0.0016. Actual base excess, mmol/L−3 (−6 to −1)−7 (−12 to −3)0.0017. Anion gap, mmol/L12.5 (10.1--15.0)15.0 (11.9--19.5)0.0018. Anion gap albumin-corrected, mmol/L15.5 (12.8--18.5)18.7 (14.8--23.6)0.0019. SIG with lactate, mmol/L4.2 (1.5--7.1)6.5 (3.0--10.8)0.00110. SIG without lactate, mmol/L2.2 (−0.3 to 5.0)2.5 (−0.4 to 5.8)0.02811. SID-effective, mmol/L33.5 (30.5--36.2)30.7 (26.7--34.7)0.00112. Other unmeasured ions, mmol/L2.1 (−1.0 to 4.9)−1.5 (−7.3 to 2.5)0.001All data are median values with the interquartile range reported in parenthesis*CO* ~*2*~ carbon dioxide, *SID* strong ion difference, *SIG* strong ion gap^a^ *p* values generated by Mann-Whitney test

SIG (with lactate: AUROC 0.631, confidence interval \[CI\] 0.611--0.652; without lactate: AUROC 0.521, 95 % CI 0.500--0.542) only had a modest ability to predict hospital mortality, and this was no better than using lactate concentration alone (AUROC 0.701, 95 % 0.682--0.721). Arterial lactate concentration, both by itself and in combination with the MPM~0~ III predicted risks (AUROC 0.824, 95 % CI 0.809--0.839), had the strongest ability to differentiate between survivors and non-survivors compared to AG (AUROC 0.660, 95 % CI 0.639--0.680), AG-corrected (AUROC 0.665, 95 % CI 0.645--0.686), SID-effective (AUROC 0.634, 95 % CI 0.613--0.655), SIG-with lactate included (AUROC 0.631, 95 % CI 0.611--0.652), SIG-without including lactate (AUROC 0.521, 95 % CI 0.500--0.542) and 'other unmeasured ions' (AUROC 0.679, 95 % CI 0.658--0.700) (all *p* values associated with these comparisons were \< 0.01) (Table [3](#Tab3){ref-type="table"}). Arterial lactate concentrations also had a good calibration in predicting mortality, with a relatively linear relationship to the risks of observed mortality ([Appendix 2](#Sec10){ref-type="sec"}). The observed hospital mortality risk of those with an admission lactate concentration \> 2 mmol/L was substantially greater than those with an admission lactate concentration ≤2 mmol/L (22.6 vs. 8.2 %, *p* = 0.001).Table 3The areas under the receiver operating characteristic curve (AUROC) of the different markers of acid-base disorders at ICU admission, with and without combining with Admission Mortality Prediction Model (MPM~0~ III) predicted risks of mortality, in differentiating between hospital survivors and non-survivors (*n* = 6878)Acid-base markersMean AUROC (95 % confidence interval \[CI\])Without MPM~0~ IIIWith MPM~0~ III1. Arterial pH0.655 (0.633--0.677)0.805 (0.789--0.821)2. Arterial CO~2~ tension0.521 (0.499--0.544)0.798 (0.782--0.814)3. Actual bicarbonate conc.0.676 (0.655--0.696)0.812 (0.796--0.828)4. Chloride conc.0.517 (0.495--0.539)0.801 (0.785--0.816)5. Lactate conc.0.701 (0.682--0.721)0.824 (0.809--0.839)6. Actual base excess0.685 (0.664--0.706)0.813 (0.797--0.829)7. Anion gap0.660 (0.639--0.680)0.813 (0.798--0.828)8. Anion gap albumin-corrected0.665 (0.645--0.686)0.818 (0.803--0.833)9. Strong ion gap (SIG) with lactate0.631 (0.611--0.652)0.812 (0.797--0.827)10. SIG without lactate0.521 (0.500--0.542)0.801 (0.786--0.817)11. Strong ion difference-effective0.634 (0.613--0.655)0.809 (0.794--0.825)12. Other unmeasured ions0.679 (0.658--0.700)0.820 (0.805--0.835)The AUROC for MPM~0~ III predicted risks of mortality alone was 0.799 (95 % CI 0.783--0.814) and SAPS III predicted risks alone was 0.833 (95 % CI 0.821--0.844). The AUROC for combining lactate with anion gap albumin-corrected and MPM~0~ III, and combining lactate with SIG and MPM~0~ III were 0.830 (95 % CI 0.816--0.845) and 0.829 (95 % CI 0.815--0.844), respectively

Adding AG-corrected (AUROC 0.830, 95 % CI 0.816--0.845) or SIG-with lactate included (AUROC 0.829, 95 % CI 0.815--0.844) to a combination of lactate and the MPM~0~ III predicted risks did increase the latter's ability to differentiate between survivors and non-survivors statistically (AUROC 0.824, 95 % CI 0.809--0.839; *p* = 0.007 and *p* = 0.014, respectively), but the magnitude of improvement was quite small (Fig. [2](#Fig2){ref-type="fig"}).Fig. 2Area under the receiver operating characteristic curves (AUROC) showing improvement in discriminative ability by combining lactate with the MPM~0~ III model compared to MPM~0~ III alone, and adding anion gap albumin-corrected or strong ion gap to lactate with MPM~0~ III did not substantially further improve the latter's ability to differentiate between survivors and non-survivors

In the multivariate logistic regression model directly comparing the significance of arterial lactate with SIG-with lactate included and SIDe, arterial lactate concentrations explained about 11 % of the variability in the observed mortality and was, by far, more important than SIG-with lactate (0.6 %) and SIDe (0.9 %), while adjusting for MPM~0~ III predicted risks (65 %).

In the sensitivity analysis involving only patients with known cirrhosis (*n* = 167), the ability of arterial lactate (AUROC 0.734, 95 % CI 0.652--0.816) to discriminate between survivors and non-survivors remained better than SIG-with lactate (AUROC 0.644, 95 % CI 0.535--0.753), SIDe (AUROC 0.616, 95 % CI 0.518--0.714) or even bilirubin concentration (AUROC 0.604, 95 % CI 0.500--0.707). Similarly, combining arterial lactate concentrations with SAPS III predicted risks of mortality (AUROC 0.852) was still better than the combination of SIG-with lactate (AUROC 0.836) or SIDe (AUROC 0.835) with the SAPS III predicted risks in differentiating between survivors and non-survivors. After centring the U-shape predictors before the ROC analyses, the improvements in AUROC for pH, chloride, bicarbonate and arterial carbon dioxide tension were small (all increments \< 0.015) and remained inferior to using lactate alone. When all acid-base markers were analysed simultaneously in a multivariate model with a 3-knot restricted cubic spline function allowing non-linearity for all predictors in the model, lactate explained 19 % of the variability in hospital mortality and remained as the strongest predictor for hospital mortality compared to other acid-base markers (Fig. [3](#Fig3){ref-type="fig"}). In this direct comparison of all acid-base markers while allowing predictors to assume a U-shape relationship, chloride became the second most important acid-base predictor (Fig. [4](#Fig4){ref-type="fig"}).Fig. 3Variability in hospital mortality explained by each acid-base marker in a multivariate model including all acid-base markers and allowing each to have a U-shape relationship with mortality by a 3-knot restricted cubic spline function. *SIG* strong ion gap. *SIDe* effective strong ion difference, *CO* ~*2*~ carbon dioxide, *HCO* ~*3*~ actual bicarbonateFig. 4A U-shape relationship between plasma chloride concentrations and hospital mortality after adjusting for all other acid-base markers. *Dotted lines* indicate 95 % confidence interval

Discussion {#Sec6}
==========

This study showed that many markers of acid-base status of critically ill patients on ICU admission were significantly different between survivors and non-survivors. Of all the acid-base markers assessed, arterial lactate concentration had the best discrimination and was better than SIG (with and without including lactate as part of its calculations) in discriminating between survivors and non-survivors---both when it was analysed on its own and simultaneously with the MPM~0~ III predicted risks of mortality. Adding SIG to a combination of lactate and MPM~0~ III predicted risks also did not greatly improve our ability to predict mortality of critically ill patients. These findings are clinically relevant and require further discussion.

Evidence suggests that Stewart's approach to acid-base may help us to identify important metabolic acid-base abnormalities that are not apparent by using the physiological or BE approach alone \[[@CR18]\]. There were also studies showing that SIG or SIDe could be better than BE, AG or lactate in predicting outcomes of critically ill patients \[[@CR5], [@CR6], [@CR19]--[@CR22]\]. However, many of these studies are relatively small, with the two largest studies (involving 410 and 935 patients) both showing an insignificant advantage by using SIG and SIDe instead of standard markers of acid-base disturbances in predicting mortality of critically ill patients \[[@CR3], [@CR23], [@CR24]\]. To the best of our knowledge, this is the largest study (*n* = 6878) assessing the prognostic significance of SIG (with and without including lactate) relative to 10 other acid-base markers in a heterogeneous group of critically ill patients, and our findings are consistent with the data from two largest published studies \[[@CR3], [@CR23]\]. Indeed, both these studies showed that lactate had the strongest ability to differentiate between survivors and non-survivors compared to SIG or SIDe (AUROC lactate: 0.67 and 0.77 vs. AUROC SIG: 0.62 and 0.67, respectively), suggesting that arterial lactate concentration should always be considered \[[@CR1]\], regardless of the approach used to assess acid-base disturbances in the critically ill. This result also supports the hypothesis that lactate concentration is a preferred resuscitation target in patients with critical illness \[[@CR25]--[@CR27]\].

So, why was SIG or SIDe not better than arterial lactate in predicting mortality in our patients? First of all, it may be too simplistic to assume, by intuition, that the prognostic significance of SIG with lactate should be better than using lactate alone just because the former includes lactate and also other biochemical variables. Although the SIG has the ability to reflect acid-base abnormalities as a result of different pathologies, its prognostic significance can also be confounded by changes in the underlying elements of SIG in different directions. Lactate is an anion and an elevated lactate concentration would be, at least in part, accounted for by an abnormal SIG, or SIDe. However, hyperlactataemia can also be 'concealed' with a relatively normal SIG, bicarbonate concentration, BE or SIDe, due to coexisting hypochloraemic alkalosis \[[@CR28]\]. As such, by combining not so important predictors with an important predictor of mortality (e.g. lactate) within the calculation of SIG, it has the potential to reduce the prognostic significance of SIG. Furthermore, an increase in other measured and unmeasured anions including ketoacids, formate, oxalate, salicylate, sulphate and phosphate \[[@CR1]\], leading to an increase in SIG (and a decrease in SIDe) without hyperlactataemia, also does not have the same prognostic significance as lactic acidosis and is more amendable to specific supportive therapy that can directly improve patient outcomes.

Second, acute and chronic and liver diseases were uncommon in our patients (2 %). Previous studies have showed that patients with liver diseases often have accumulation of unmeasured anions in addition to lactate \[[@CR15], [@CR16]\]; hence, SIG and SIDe may have a stronger prognostic significance than using lactate alone for these patients. Third, we assessed the prognostic significance of all the markers of acid-base disturbances in blood samples obtained within the first hour of ICU admission. It is well established that administering large quantity of intravenous fluid to critically ill patients can alter their acid-base status through multiple mechanisms, including inducing hyperchloraemic acidosis and dilutional hypoalbuminaemia. Whether SIG and SIDe may have a stronger association with mortality than arterial lactate in the later phase of critical illness after a large quantity of intravenous fluid is used for resuscitation remains uncertain, and this merits further evaluation.

Although 'other unmeasured ions' (or BE gap) is theoretically similar to SIG calculated without lactate and has received considerable attention over the years \[[@CR29], [@CR30]\], it is not simple to use and was not as good as lactate, both alone and in combination with MPM~0~ III predicted risks, in predicting mortality of the critically ill. In addition, our study also showed that arterial carbon dioxide tension (AUROC 0.521) and chloride concentrations (AUROC 0.517) were not as important as arterial lactate concentrations in discriminating between survivors and non-survivors. This may be due to the fact that the underlying causes for both respiratory acidosis and hyperchloraemia are usually obvious to the treating clinicians and are also more readily treatable than lactic acidosis using mechanical ventilation and sodium bicarbonate or diuretics, respectively.

This study has some limitations. First, although we had included a large number of patients and our results were consistent with largest published studies \[[@CR3], [@CR23]\], this was still a single-centre study potentially limiting its general applicability and to different specific subgroups of critically ill patients, especially those with acute liver failure. Second, inherent to all diagnostic tests, noting abnormal results from a diagnostic test is not necessarily translatable to improved outcomes, unless the underlying pathological process reflected by the diagnostic test can be identified and modified. Finally, temporal changes in acid-base markers during the course of critical illness and after different interventions are common and may affect the prognostic significance of each acid-base marker differently. Whether serial lactate concentrations are the most important acid-base marker to be targeted in the critically ill remains uncertain \[[@CR25], [@CR27]\], and this merits further investigation.

Conclusions {#Sec7}
===========

In conclusion, many markers of acid-base status in critically ill patients were significantly different between survivors and non-survivors. The prognostic significance of SIG was modest and inferior to arterial lactate concentration for the critically ill. Of all the acid-base markers assessed in this large cohort study, arterial lactate concentration had the best discrimination---both when it was analysed on its own and simultaneously with the MPM~0~ III predicted risks of mortality or other acid-base markers while allowing a U-shape relationship for all acid-base markers---suggesting that arterial lactate concentration is the important marker of acid-base disorders in determining mortality outcome of critically ill patients. Lactate concentration should always be considered regardless of which approach is used to interpret acid-base disturbances in critically ill patients; a high lactate concentration can be considered as a simple, and yet, important warning acid-base marker for patients who are at risk of dying from critical illness.

Appendices {#Sec8}
==========

Appendix 1 {#Sec9}
----------

Calculated acid-base variables:

Anion gap = \[Na^+^\] + \[K^+^\] − \[Cl^−^\] − \[HCO~3~^−^\]

Anion gap albumin-corrected = anion gap + 0.25 × (42 − observed albumin in g/L)

Strong ion difference-effective (SIDe) = \[HCO~3~^−^\] + \[albumin\] × (0.123 × pH − 0.631) + 2 × \[phosphate\] × (0.309 × pH − 0.469)

Strong ion difference-apparent (SIDa) = \[Na^+^\] + \[K^+^\] + 2 × \[Ca^2+^\] + 2 × \[Mg^2+^\] − \[Cl^−^\] − \[lactate\]

Strong ion difference-apparent (SIDa with lactate included) = \[Na+\] + \[K+\] + 2 × \[Ca^2+^\] + 2 × \[Mg^2+^\] − \[Cl^−^\]

Strong ion gap = (strong ion difference-apparent) − (strong ion difference-effective)

Strong ion gap with lactate included = (strong ion difference-apparent with lactate) − (strong ion difference-effective)

'Other unmeasured ions' = base excess (BE) − 'protein effect' − 'chloride effect' − 'water effect' = BE − (0.148 × pH − 0.818) × (42 − measured albumin in g/L) − (102 − measured \[Cl^−^\] × 140/measured \[Na^+^\]) − 0.3 × (measured \[Na^+^\] − 140)

Arterial blood gases including lactate, chloride concentrations were measured by ABL800 FLEX blood gas analyser (Radiometer®, Copenhagen, Denmark) (bias and precision are described in http://www.radiometeramerica.com/\~/media/files/radiometercomcloneset/rame/manuals/abl800/989-963i%20abl800%20reference%20manual%20-%20english%20us.Pdf?bcsi_scan_313cddce030931be=sI53xPnlknYjOddC3jutx1ef6TcKAAAA7PkeTA==&bcsi_scan_filename=989-963i%20abl800%20reference%20manual%20-%20english%20us.Pdf ).

All concentration measurements used in the calculations are based on millimole per litre.

Appendix 2 {#Sec10}
----------

Scatter plots showed no extreme U-shape relationships between observed risks of mortality and different markers of acid-base status which may substantially compromise the receiver operating characteristic (ROC) analyses. All error bars in the graphs in [Appendix 2](#Sec10){ref-type="sec"} signify 95 % confidence interval of the observed hospital mortality risk for subgroup of patients with the value of the associated acid-base marker on admission to the intensive care unit (Fig. 5).

Fig. 5**a** Arterial pH. **b** Arterial carbon dioxide tension. **c** Arterial bicarbonate concentration. **d** Chloride. **e** Arterial lactate. **f** Base excess. **g** Anion gap. **h** Anion gap albumin-corrected. **i** Strong ion gap including lactate. **j** Strong ion gap (without including lactate). **k** Strong ion difference (SIDe). **l** Other unmeasured ions
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:   Area under the receiver operating characteristic curve

ICU

:   Intensive care unit

MPM

:   Mortality Prediction Model

SAPS

:   Simplified Acute Physiology Score

SID

:   Strong ion difference

SIG

:   Strong ion gap
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